Deal Description

A State-of the-Art Pharmaceutical Research and Developement Facility which started in the year 2009. It is a contract research and manufacturing organization operating within the generic pharmaceutical market whilst providing a diverse portfolio of services to pharmaceutical and R&D Centers across the globe. Commissioned by experienced pharmaceutical professionals having wide global exposure and having capacity to develop ANDAs and First-To-File formulations.

The activities done are as follows:-

1. Formulation development and Process Validiation
2. Analytical method development and Method Valuation
3. Technology Transfer to CMO
4. Stability studies as per ICH Guidelines
5. Manufacturing of Clinical/ Bio-Batch for BE/ Clinical Studies
6. Commercial Manufacturing of Tablets, Pellets, Powders, and Sachets for export market with to Europe approved facility

Products which will be provided are as follows:-

1. Tablets (Coated and Uncoated) = Immediate Release, Modified Release, Effervescent, Orodispersible, Chewable, and Bi-Layered Tablets
2. Capsule
3. Granules
4. Pellets

The services that are offered are:-

1. Research and Development
2. Technology Transfer
3. Stability
4. Commercial Supply

The funds we are raising are required for:-

1. Man Power
2. Capex
3. Bioequivalence Studies
4. Dossier Acquisition
5. New Product Development

The Revenue of the company during the previous years are as follows:-

1. 2021-22 = ₹ 2.23 Cr
2. 2020-21 = ₹ 4.24 Cr
3. 2019-20 = ₹ 5.58 Cr

No Files Attached